Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Will appellate body uphold grant of compulsory licence to cancer drug?
Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week
Novartis loses patent appeal in landmark suit
Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …